Landscapes / Companies
Kiora Pharmaceuticals, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
Drugs
2
in active trials · 4 in all
Trials
2 active
5 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | Nov 2026soonPhase 2 trial completes | |||
| Next date | Nov 2026 · Phase 2 trial completes | ||||
| Also tested for | Macular Edema | ||||
| Open drug page | |||||
— |
Phase 2 | Aug 2027Phase 2 trial completes | |||
| Next date | Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Retinitis Pigmentosa | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021